← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Baebies, Inc.
Durham, NC
$45,194,269
Total funding
28
Grants
Funding over time
peak $6.7M · FY2013–25$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,194,269 · 28
By mechanism
R44$39,619,518 · 20
N43$4,699,384 · 4
R43$875,367 · 4
Investigators at Baebies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
A Multifunctional Point of- Care Platform to Differentiate HIV Infection from Vaccine Induced Seropositivity$1,999,995
N43 · FY2025 · AI
Rapid, Point-of-Care Diagnostics for Hepatitis C Virus$1,499,998
N43 · FY2022 · AI
A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance$1,000,723
R44 · FY2025 · AI
Rapid Differential Diagnosis of COVID-19 and Common Respiratory Infections$1,000,000
R44 · FY2021 · AI
Multiplex Platform for Point-of-Care Newborn Screening of Hyperbilirubinemia$999,995
R44 · FY2019 · HD
A Near-Patient, Low Blood Volume Platform for Rapid Comprehensive Evaluation of Coagulation in Trauma Patients$999,362
R44 · FY2025 · HL
A Near-Patient, Low Blood Volume Platform for Rapid Comprehensive Evaluation of Coagulation in Trauma Patients$998,891
R44 · FY2024 · HL
Digital Microfluidics - Minimizing Blood Volume for Pediatric Coagulation Screening$995,191
R44 · FY2020 · HL
Digital Microfluidics - Minimizing Blood Volume for Pediatric Coagulation Screening$995,038
R44 · FY2022 · HL
Digital Microfluidics - Minimizing Blood Volume for Pediatric Coagulation Screening$994,792
R44 · FY2021 · HL
A Low Blood Volume Platform for Recurrent Anticoagulation and Kidney Monitoring during Continuous Renal Replacement Therapy in Critically Ill Children$948,080
R44 · FY2024 · HL
Multiplex Platform for Point-of-Care Newborn Screening of Hyperbilirubinemia$938,890
R44 · FY2020 · HD
Point-of-birth newborn screening for MCAD/VLCAD and galactosemia to eliminate deadly delays for time critical conditions$917,787
R44 · FY2017 · HD
Expanding thyroid testing in high risk newborns: total T3, free T4, TSH and TRAB$916,266
R44 · FY2018 · HD
Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection$912,027
R44 · FY2021 · HL
Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection$878,833
R44 · FY2022 · HL
Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection$863,466
R44 · FY2023 · HL
Lab-on-a-Chip for Multiplexed Newborn Screening of Lysosomal Storage Disorders$840,393
R44 · FY2014 · HD
A Low Blood Volume Platform for Recurrent Anticoagulation and Kidney Monitoring during Continuous Renal Replacement Therapy in Critically Ill Children$830,640
R44 · FY2023 · HL
Improving Anticoagulation Monitoring in Pediatric Patients: Use of a Microfluidic Platform to Test Low Volume Blood Samples Obtained by Heel-Stick Collection$807,306
R44 · FY2018 · HL